Cytokinetics reported $76.5M in Current Liabilities for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 116.57M 1.11M
Amgen AMGN:US USD 14.33B 1.71B
Arca Biopharma ABIO:US USD 3.5M 618K
Bayer BAYN:GR EUR 33.17B 471M
Biogen BIIB:US USD 3.93B 1.09B
Brainstorm Cell Therapeutics BCLI:US USD 8.95M 1.1M
Bristol Myers Squibb BMY:US USD 18.93B 1.98B
Capricor Therapeutics CAPR:US USD 23.2M 3.65M
Cytokinetics CYTK:US USD 76.5M 9.65M
Eisai 4523:JP JPY 266.54B 35.36B
Eli Lilly And LLY:US USD 15.65B 32.2M
Exelixis EXEL:US USD 301.73M 2.79M
Geron GERN:US USD 82.81M 35.93M
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Intra Cellular Therapies ITCI:US USD 77.41M 6.78M
IONIS PHARMACEUT IONS:US USD 283.45M 15.64M
Ligand Pharmaceuticals LGND:US USD 135.24M 32.61M
Novartis NOVN:VX USD 28.16B 514M
Regeneron Pharmaceuticals REGN:US USD 2.88B 154.7M
Roche Holding ROG:VX 27.41B 11.01B